Non-alcoholic fatty liver disease (Q43578): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
DHGNA (doença hepática gordurosa não alcoólica) é caracterizada por fígado gorduroso relacionado à resistência a insulina na ausência de consumo alcoólico significativo. Abrange um espectro patológico desde estatose simples até esteatohepatite. Cerca de 10 a 20% dos casos têm esteatohepatite (esteatohepatite não alcoólica: NASH), que pode progredir para cirrose e carcinoma hepatocelular. | |||
| description / en | description / en | ||
NAFLD is characterised by fatty liver related to insulin resistance in the absence of significant alcohol consumption. It embraces a pathological spectrum from simple steatosis to steatohepatitis. 10-20% of cases have steatohepatitis (non-alcoholic steatohepatitis: NASH), which can progress to cirrhosis and hepatocellular carcinoma. | |||
Revision as of 10:39, 13 August 2026
NAFLD is characterised by fatty liver related to insulin resistance in the absence of significant alcohol consumption. It embraces a pathological spectrum from simple steatosis to steatohepatitis. 10-20% of cases have steatohepatitis (non-alcoholic steatohepatitis: NASH), which can progress to cirrhosis and hepatocellular carcinoma.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | DB92 |
||
| English | Non-alcoholic fatty liver disease |
NAFLD is characterised by fatty liver related to insulin resistance in the absence of significant alcohol consumption. It embraces a pathological spectrum from simple steatosis to steatohepatitis. 10-20% of cases have steatohepatitis (non-alcoholic steatohepatitis: NASH), which can progress to cirrhosis and hepatocellular carcinoma. |
